reports
- Nicholas Cortellucci
- CFA
Finding the Next Takeout in Canadian Small-Caps - Part Three
What you need to know: • Since our last note in May, there have been 10 additional takeouts in Canadian small-caps, most of which coming in a significant premiums. • The new acquisitions largely fit within the framework outlined in previous reports. • Our potential takeouts portfolio is up 43% since inception (November 2023) and 17% since our last note, compared to the TSX up 18% and 3% respectively. We review the biggest winners and losers in the portfolio and present a list of new ideas on ou...
GCL COLABOR GROUP INC
COV. COVALON TECHNOLOGIES LTD.
CTX CRESCITA THERAPEUTICS
E ENTERPRISE GROUP
IFX IMAFLEX INC. CL A
MAL MAGELLAN AEROSPACE CORP.
SYZ SYLOGIST LTD.
KUT REDISHRED CAPITAL CORP.
GSI. GATEKEEPER SYSTEMS INC
QIS CN QUORUM INFORMATION TECHNOLOGIES INC
XYBN XYBION DIGITAL INC
GRID TANTALUS SYSTEMS HLDG INC
HAI HAIVISION SYSTEMS INC
CNG KRAKEN ROBOTICS INC
BQE BQE WATER INC.
OSS ONESOFT SOLUTIONS INC
Covalon Technologies Ltd: 1 director sold
A director at Covalon Technologies Ltd sold 25,000 shares at 0.000CAD and the significance rating of the trade was 51/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years...
Covalon Announces Major Sales Breakthrough – Wins Contracts with an ...
MISSISSAUGA, Ontario--(BUSINESS WIRE)-- Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, has been informed that it has won a series of competitive contracts in the Middle East with an estimated sales value of $100 million over a three-year period. The series of competitive contracts awarded to Covalon includes the granting of approximately ten categories of products under the Executive Board of Health Ministers’ Council for Gulf Cooperation Council Sta...
Covalon to Showcase MediClearâ„¢ PreOp at AATS 2018 Annual Meeting
MISSISSAUGA, Ontario--(BUSINESS WIRE)-- Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced that it will be showcasing its perioperative suite of innovative products, including MediClear™ PreOp, at the American Association for Thoracic Surgery (“AATS”) Annual Meeting. MediClear PreOp is the market’s first breathable and transparent antimicrobial self-adherent silicone drape for preoperative skin. Its polyurethane barrier film acts as a pro...
New Clinical Data for Covalon’s ColActive® Line of Patented Advance...
MISSISSAUGA, Ontario--(BUSINESS WIRE)-- Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV), an advanced medical technologies company, today announced that two clinical case studies demonstrating the clinical effectiveness of ColActive® Plus and ColActive® Transfer biological matrix products will be presented at the 2018 Symposium on Advanced Wound Care Spring (“SAWC Spring”) in Charlotte, North Carolina. In addition to the posters, Covalon will also be showcasing its full line of advanced wound care dressings in the sy...
Covalon Announces Voting Results from 2018 Annual Meeting of Sharehold...
MISSISSAUGA, Ontario--(BUSINESS WIRE)-- Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV), an advanced medical technologies company, today announced the results of the matters voted upon at the Company’s 2018 Annual Meeting of Shareholders held March 8th 2018. Shareholders voted in favour of all items of business and each was approved by the requisite number of votes. The matters included the election of the board of directors, the appointment of auditors, and the approval of the Company’s stock option plan. ...
Covalon’s MediClear™ PreOp Receives Frost & Sullivan’s 2018 Nort...
MISSISSAUGA, Ontario--(BUSINESS WIRE)-- Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, announced today its MediClear™ PreOp has received Frost & Sullivan’s 2018 North American Surgical Site Infection Prevention New Product Innovation Award. MediClear PreOp is the market’s only antimicrobial self-adherent silicone film drape for pre-operative skin that provides continuous antimicrobial activity to reduce the risk of bacterial contamination of a patient’s skin ...
Covalon Announces Strong First Quarter Financial Results
MISSISSAUGA, Ontario--(BUSINESS WIRE)-- Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, announced today its first quarter financial results. First Quarter Summary Financial Results Revenue for the three months ended December 31, 2017 was $6,404,705. Gross margin for the quarter ended December 31, 2017 was 71%. Net income for the quarter was $523,345 or $0.02 per share. CEO Comment ...
Covalon Announces Conference Call to Discuss Q1 Financial Results
MISSISSAUGA, Ontario--(BUSINESS WIRE)-- Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV), an advanced medical technologies company, has scheduled a conference call to be held Tuesday February 13th 2018 at 9:00 a.m. EST, to discuss the financial results of the first quarter ended December 31st 2017. The Company intends to release its Q1 financial results on Monday February 12th 2018. To participate in the live call, please dial: Local / International: 647-792-1278North American Toll-Free: 1 86...
Covalon to Showcase Centaurâ„¢ Low Particulate, Lubricious Coating at ...
MISSISSAUGA, Ontario--(BUSINESS WIRE)-- Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV), an advanced medical technologies company, today announced that it will be featuring its commercially available platform technologies, including the recently launched Centaur™ coating as first-time exhibitors at North America’s largest annual MedTech event. MD&M West will take place at the Anaheim Convention Center, from February 6-8, 2018. In a third party in vitro simulated vascular insertion study designed to measure ...
Covalon Announces Issuance of Stock Options
MISSISSAUGA, Ontario--(BUSINESS WIRE)-- Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), today announced the issuance of an aggregate of 187,500 stock options to employees, directors and consultants of the Company. The stock options will vest over three years and will be exercisable for a period of five years at an exercise price of $4.65 per stock option. About CovalonCovalon Technologies Ltd. researches, develops and commercializes new healthcare technologies that help save lives around the ...
Covalon Announces Record Positive Results for Fiscal 2017
MISSISSAUGA, Ontario--(BUSINESS WIRE)-- Mr. Brian Pedlar, President and CEO of Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), is delighted to announce that Covalon has achieved the best financial results in its history for the fiscal 2017 year-end. Fiscal 2017 Summary Results Total revenue for the three months ended September 30, 2017, increased 1,027% to $9,836,953 compared to $872,570 for the same period of the prior year. Total revenue for the y...
- GlobalData Healthcare Department
Covalon Technologies Ltd (COV) - Pharmaceuticals & Healthcare - Deals ...
Summary Covalon Technologies Ltd (Covalon) is a researcher, developer and commercialization of medical devices and healthcare technologies. The company offers advanced wound solutions, infection prevention products and perioperative care products. Covalon offers wound care products such as collagen matrix dressing, collagen matrix dressing with silver, wound contact layer, non-adherent foam dressing and superabsorbent dressing, among others. Its infection prevention products and perioperative c...
Covalon to Feature its Advanced Wound Management and Infection Prevent...
MISSISSAUGA, Ontario--(BUSINESS WIRE)-- Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV), an advanced medical technologies company, announced today that it will be showcasing its full portfolio of Advanced Wound Management and Infection Prevention products at the Limb Salvage and Woundcare Symposium in Cleveland, Ohio on October 6th and 7th, 2017. The Company’s CovaWound™, ColActive®, and MediClear™ PreOp brands have strong evidence to support their efficacy in killing the bacteria most commonly associated w...
Covalon Announces Major Milestone: FDA Clearance for MediClearâ„¢ PreO...
MISSISSAUGA, Ontario--(BUSINESS WIRE)-- Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, announced today it has received United States Food and Drug Administration (“FDA”) clearance to legally market and sell MediClear™ PreOp in the US to hospitals, clinics and directly to patients, without the need for a prescription. MediClear PreOp is a breathable, transparent, self-adhesive, silicone barrier film-drape that smoothly conforms to the contours of a pa...
Covalon Announces the Commencement of Trading on the OTCQX Market in t...
MISSISSAUGA, Ontario--(BUSINESS WIRE)-- Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV:COV; OTCQX:CVALF), an advanced medical technologies company, today announced that shares of the Company have commenced trading on the OTCQX® Best Market— an established public market in the United States. While the Company will continue to trade on the TSX Venture Exchange under the symbol “COV”, investors will now also have the opportunity to trade the Company’s shares under the symbol “CVALF” on OTCQX. The OTCQX is a United ...
Covalon Announces $14 Million in New Contract Orders in the Middle Eas...
MISSISSAUGA, Ontario--(BUSINESS WIRE)-- Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV), an advanced medical technologies company, today announced that it has received $14 million of new orders under exclusive contracts that it has won in the Middle East. The contract orders have been received as a result of the Company being granted major contracts to supply several of its advanced dressing products to Ministry of Health facilities in Saudi Arabia and other Gulf Cooperation Council (“GCC”) countries. The contracts ...
Covalon Releases Third Quarter Financial Results
MISSISSAUGA, Ontario--(BUSINESS WIRE)-- Covalon Technologies Ltd.: 200% growth in revenue for the nine months ended June 30, 2017 Revenue of $17.5 million for the nine-month period and profit of $1.6 million Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV), an advanced medical technologies company, announced today its second quarter financial results, which included revenue of $5,901,622 and net income of $541,346 or $0.02 per share for the three months ended June ...
Covalon Announces Conference Call to Discuss Q3 Financial Results
MISSISSAUGA, Ontario--(BUSINESS WIRE)-- Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV), an advanced medical technologies company, has scheduled a conference call to be held Tuesday August 22, 2017 at 9:00 a.m. EDT, to discuss the third quarter ended June 30, 2017, financial results. The Company intends to release its Q3 financial results on Monday August 21, 2017. The call will be held Tuesday, August 22, 2017 at 9:00 a.m. EDT. To participate in the live call please dial: Local / Internat...
Covalon To Feature IV Clear at APHON Pediatric Conference
MISSISSAUGA, Ontario--(BUSINESS WIRE)-- Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV), an advanced medical technologies company, today announced that it will be featuring IV Clear while exhibiting for the first time at the 41st Association of Pediatric Hematology/Oncology Nurses annual conference and exhibit at the Palm Springs Convention Center, from August 17-19, 2017. Along with IV Clear, Covalon will feature its proprietary line of infection management dressings for both the perioperative and vascular...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.